12 September 2025 | Friday | News
Olympus Corp. of the Americas is proud to announce the new iTind™ Center of Excellence (COE) Program, which is designed to enhance care, experience and outcomes for men suffering from symptoms associated with benign prostatic hyperplasia (BPH), known as enlarged prostate.
In its inaugural year, the iTind Center of Excellence Program welcomes three members: C. Cragin Anderson, MD, FACS, a board-certified urologist with Colorado Urology; Petar Bajic, MD, a board-certified urologist and Director of Men's Health at Glickman Urological Institute, Cleveland Clinic; and Alex M. Kandabarow, MD, a board-certified urologist with Virginia Hospital Center Health Urology – Kingstowne.
"We are thrilled to welcome these inaugural members to the iTind Center of Excellence Program," said Matt Woodward, Vice President and Regional Business Lead for Urology at Olympus. "Patients suffering from enlarged prostate need to know that there are safe and effective alternatives to medications and invasive surgeries for relieving urinary symptoms that can seriously affect their quality of life. Our relationship with these physicians is centered on excellence in patient care and experience and aimed towards improving patient outcomes in BPH treatment."
Benchmarks for achieving an iTind Center of Excellence status for a urologist treating patients with the iTind procedure include, but are not limited to:
© 2025 Biopharma Boardroom. All Rights Reserved.